$64.99

Last traded 2018-11-21 — delisted

NASDAQ · Healthcare · Medical - Equipment & Services

Revenue

$7.3B -0.1% ▼

5Y CAGR: +12.6%

Gross Profit

$3.2B -0.3% ▼

5Y CAGR: +10.2%

Operating Income

$318M -16.0% ▼

5Y CAGR: -2.5%

Net Income

$102M -16.0% ▼

5Y CAGR: -7.6%

EPS (Diluted)

$2.51 -11.0% ▼

5Y CAGR: -4.4%

EBITDA

$668M -7.6% ▼

5Y CAGR: +3.8%

View Full Income Statement

Line Item	FY2013	FY2014	FY2015	FY2016	FY2017
Revenue	$4.4B	$5.3B	$6.0B	$7.3B	$7.3B
YoY Growth	+10.3%	+19.7%	+13.5%	+20.9%	-0.1%
Cost of Revenue	$2.3B	$2.8B	$3.3B	$4.1B	$4.1B
Gross Profit	$2.1B	$2.5B	$2.7B	$3.2B	$3.2B
Gross Margin	48.0%	46.5%	44.9%	43.4%	43.4%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$316M	$368M	$423M	$553M	$520M
Operating Expenses	$1.8B	$2.1B	$2.3B	$2.8B	$2.8B
Operating Income	$303M	$441M	$440M	$378M	$318M
Operating Margin	6.8%	8.3%	7.3%	5.2%	4.4%
Interest Expense	$103M	$123M	$114M	$171M	$149M
Income Before Tax	$212M	$203M	$302M	$205M	$160M
Tax Expense	$79M	$68M	$110M	$73M	$47M
Net Income	$128M	$126M	$182M	$122M	$102M
Net Margin	2.9%	2.4%	3.0%	1.7%	1.4%
EPS (Diluted)	$2.69	$2.69	$3.95	$2.82	$2.51
EBITDA	$531M	$692M	$720M	$723M	$668M
Shares Outstanding	48M	47M	46M	43M	41M

Line Item	FY2016 Q4	FY2017 Q1	FY2017 Q2	FY2017 Q3	FY2017 Q4	FY2018 Q1	FY2018 Q2	FY2018 Q3
Revenue	$1.8B	$1.9B	$1.8B	$1.8B	$1.8B	$1.6B	$1.6B	$1.6B
Cost of Revenue	$1.0B	$1.1B	$1.0B	$1.0B	$1.0B	$1.0B	$996M	$1.0B
Gross Profit	$796M	$799M	$797M	$794M	$762M	$574M	$574M	$541M
Gross Margin	43.4%	42.9%	43.7%	44.0%	43.0%	35.8%	36.5%	34.8%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$130M	$130M	$132M	$135M	$122M	$131M	$134M	$136M
Operating Expenses	$686M	$691M	$693M	$705M	$744M	$474M	$474M	$467M
Operating Income	$109M	$82M	$104M	$89M	$18M	$100M	$100M	$74M
Operating Margin	6.0%	4.4%	5.7%	4.9%	1.0%	6.3%	6.4%	4.8%
Interest Expense	$36M	$37M	$33M	$37M	$36M	$37M	$37M	$37M
Income Before Tax	$73M	$96M	$70M	$55M	-$62M	-$3M	$72M	$4M
Tax Expense	$26M	$32M	$24M	$25M	-$35M	$2M	$17M	-$19M
Net Income	$44M	$60M	$42M	$28M	-$27M	-$5M	$52M	$22M
Net Margin	2.4%	3.2%	2.3%	1.5%	-1.5%	-0.3%	3.3%	1.4%
EPS (Diluted)	$1.07	$1.46	$1.03	$0.67	$-0.69	$-0.14	$1.33	$0.56
EBITDA	$197M	$170M	$192M	$176M	$104M	$182M	$181M	$155M
Shares Outstanding	41M	41M	41M	41M	39M	39M	40M	40M

LPNT NASDAQ